Despite lacking a fresh news catalyst, Apttorum turned out to be the MVP of my trading day.

Aptorum Group is a clinical-stage biopharmaceutical company based in the UK, dedicated to the exploration, development, and commercialization of therapeutic assets for the treatment of diseases with unmet medical needs.